Postoperative urinary tract infections (UTIs) following single-dose intraoperative antibiotic prophylaxis in colposuspension patients

被引：1

作者：

Chilaka V.N. ^{[1
,2
]}

Mayne C.J. ^{[1
]}

机构：

[1] Leicester General Hospital, Leicester

[2] Urogynecology Unit, Department of Obstetrics and Gynecology, Leicester General Hospital, Leicester LE5 4WP, Gwendolen Road

来源：

International Urogynecology Journal | 1998年 / 9卷 / 3期

关键词：

Antibiotic prophylaxis; Colposuspension; Intermittent self-catheterization; Suprapublic catheterization; UTI;

D O I：

10.1007/BF02001080

中图分类号：

学科分类号：

摘要：

The records of 196 women who underwent colposuspension for genuine stress incontinence at the Leicester General Hospital, England, between June 1991 and May 1996 were reviewed for evidence of urinary tract infection (UTI). Variables analyzed include age, type of anbibiotic, timing of a positive culture, organism(s) responsible and antibiotic sensitivity. Forty-six patients (23.47%) developed urinary infection; of these, 42 had received single-dose antibiotic prophylaxis with suprapubic catheterization. Thirty-two (76%) of those who developed UTI received augmentin (amoxycillin and clavulanic acid), whereas 10 (24%) were given cefuroxime and metronidazole. Positive cultures were obtained between postoperative days 3 and 28, with a mean of 9.6 days, and 81% occurred after the 7th day. Coliform organisms were responsible for nearly 70% of the infections. UTI is still common after colposuspension, despite single-dose antibiotic prophylaxis. Further studies looking at longer or alternative courses of antibiotics or clean intermittent self-catheterization are essential to establish the best way of curbing UTI in urogynecology patients.

引用

页码：132 / 135

页数：3

共 15 条

[1] Mendelson J., Perincy J., De Saint Victor J.R., Gelfend M.M., Effect of single dose and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy, Obstet Gynecol, 53, pp. 31-35, (1979)
[2] Hemsell D.L., Cunningham F.G., Kappus S., Nobles B., Cefoxitin for prophylaxis in pre-menopausal women undergoing vaginal hysterectomy, Obstet Gynecol, 56, pp. 629-634, (1980)
[3] Korda A., Ferry J., Hunter P., Colposuspension for the treatment of female urinary incontinence, Aust NZ J Obstet Gynaecol, 29, pp. 146-149, (1989)
[4] Kjolhede P., Ryden G., Prognostic factors and long-term results of the Burch colposuspension. A retrospective study, Act Obstet Gynecol Scand, 73, pp. 642-647, (1994)
[5] Mitteendorf R., Aronson M.P., Berry R.E., Et al., Avoiding serious infections associated with abdominal hysterectomy: A meta-analysis of antibiotic prophylaxis, Am J Obstet Gynecol, 169, pp. 1119-1124, (1993)
[6] McDonald P.J., O'Loughlin J.A., Prophylactic antibiotics and prevention of surgical sepsis, Baillieres Clin Obstet Gynecol, 7, pp. 219-236, (1993)
[7] Gorbach S.L., Condon R.E., Conte Jr. J.E., Kaiser A.B., Ledger W.J., Nichols R.L., Evaluation of new anti-infective drugs for surgical prophylaxis, Clin Infect Dis, 15, 1 SUPPL., (1992)
[8] Mcdonald P.J., Sanders R., Turnidge J., Optimal duration of cefotaxime prophylaxis in abdominal and vaginal hysterectomy, Drugs, 35, pp. 216-220, (1988)
[9] Van Der Wall E., Verkooyen R.P., Mintjes-De Groot J., Et al., Prophylactic ciprofloxacin for catheter-associated urinary-tract infection, Lancet, 339, pp. 946-951, (1992)
[10] Rutschmann O.T., Zwahlen A., Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients, Eur J Clin Microbiol Infect Dis, 14, pp. 441-444, (1995)

← 1 2 →